(C) RSNA, 2010″
“Aim:

To evaluate patterns of care and equity of access to assisted reproductive technology (ART) for cancer patients in Australia

Methods:

A review of state and national legislation and Medicare numbers relevant to ART and phone interviews with representative fertility facilities in each State and Territory.

Results:

There appears to be little legal restriction to ART for cancer

patients although in some states, clinical practice is in fact contrary to GSK1838705A ic50 legislation. The cost of ART is influenced by Medicare rebates and the overall cost of fertility treatments as set out by the specific fertility unit. There is no rebate for embryo and sperm storage. Costs of receiving an ART intervention vary greatly. Out-of-pocket costs ranged from nil to approximately $3000 per year for an in vitro fertilization or intracytoplasmic sperm injection cycle, from nil to $700 for embryo storage and from nil to $1500 for embryo transfer. All but two of the fertility clinics felt selleck compound that the numbers of oncology patients accessing ART were low. The most common barrier to access identified by

the fertility clinics interviewed was time restriction in a setting where there is a time pressure for a patient to commence anti-cancer treatment.

Conclusion:

Legislation is unlikely to be a barrier to the use of ART by cancer patients. The main reasons for limited access to ART may be cost or other factors including time pressure, the lack of a partner and age. Further research in this area is warranted.”
“CsTiOAsO4 has been found to be phase-matchable for type-2 second-harmonic

generation and Alisertib mouse sum-frequency generation in the 0.5321-1.5915 mu m range at 20.0 degrees C. The Sellmeier equations that correctly reproduce these experimental data as well as the 90 degrees phase-matched optical parametric oscillator wavelengths in the 0.7337-2.4793 mu m range are presented together with the thermo-optic dispersion formula. (C) 2011 American Institute of Physics. [doi:10.1063/1.3525800]“
“Purpose: To determine the appropriate radiologic criteria of metastatic retropharyngeal lymph nodes (RLNs) in patients with nasopharyngeal carcinoma (NPC).

Materials and Methods: After institutional review board approval and informed consent, 303 consecutive NPC patients treated with definitive radiation therapy were examined after completion of therapy. RLNs were classified as metastatic on the basis of the results of magnetic resonance (MR) imaging follow-up. The receiver operating characteristic curve and area under the curve were determined to assess the accuracy of different size criteria in the diagnosis of RLN metastasis.

Results: Initial MR images revealed 523 RLNs in 265 patients. Two hundred sixty-four (50.5%) RLNs positive for malignant involvement were confirmed in 177 patients. The remaining 259 (49.